Herald Trades an Activist Discount, Not a 66% Exit

Summary: Herald Investment Trust still trades on an 8% discount even after its board published a deliverable exit structure, locked Saba into a full in specie tender, and put Aberdeen behind the continuation vehicle. This is not a pure stock-picking call on small-cap tech. It is a governance discount that still has not caught up with its own exit math.

Opportunity Ranking

Rank	Idea	Discovery Lane	Why It May Be Best Now	Evidence Freshness	Catalyst Window	Asymmetry	Main Reason to Reject
1	Herald Investment Trust (LSE: HRI)	Europe / UK lane	Board-backed 66% tender, Saba standstill, and an 8% live discount still on screen	7 May RNS, 13 May portfolio report, 18 May NAV and live quote	End-May circular, late-June vote, July completion	Medium-high	n/a
2	AISIN Corporation (TYO: 7259)	Japan lane	Official buyback and tender absorb Toyota group supply with real shrink	28 Apr and 11 May AISIN filings	Ongoing repurchase and tender settlement	Medium	The tender price sits below spot, so common-stock upside is slower and less direct than Herald's discount compression
3	Expensify (Nasdaq: EXFY)	U.S. lane	The issuer is willing to retire 25% to 30% of the float in a Dutch tender	13 May SEC tender materials and 19 May live quote	10 Jun tender expiry	Low-medium	At $1.15, the tape already sits close to the $1.20 ceiling, leaving thin upside and real proration risk

Selected opportunity: Herald Investment Trust (LSE: HRI)

Why this one now: The setup combines public math, a dated catalyst path, and a liquid quoted discount. The other lanes had a story. Herald has a structure.

What should surprise the reader: The market is still valuing Herald like an unresolved activist fight, even though the board has already turned the activist into the capacity provider for everyone else's cash exit.

Why This Is the Best Opportunity Right Now

Herald is the rare special situation where the board has already shown its work. On 7 May, Herald said it would offer up to 66% of the share count in a tender, split between a 33% in specie option and a 33% cash option, with unused capacity from either side able to spill over to the other. Saba, which Herald says owns about 30% of the shares, agreed to tender its entire stake in specie, vote for the deal, stop agitating, and stop shorting the stock through the 2029 AGM if the plan is implemented by 30 September 2026. Aberdeen will take over as AIFM, Katie Potts stays in place, and the investment mandate does not change. That is not narrative. That is a published term sheet with dates and obligations. Source

The market still gives you the shares on a meaningful discount. Fidelity showed HRI at 3,000p bid and 3,015p offer, with an estimated NAV of 3,263.28p and a quoted 8.07% discount, updated at 18 May 2026 23:49 Singapore time. Herald's official RNS NAV, published on 18 May for 15 May, was 3,321.44p excluding current-year income. Source Source

That is enough to make this the best live setup in the screen. The trade is not heroic. The spread is visible.

What Should Surprise the Reader

The surprise is not that Herald trades below NAV. Plenty of investment trusts do. The surprise is that Herald still trades like the activist overhang is the problem when the activist has already agreed to leave, in specie, on board-approved terms. The market is still charging orphan-risk pricing to a structure that now has an exit lane, a standstill, and a successor platform.

The Setup

Herald's 7 May announcement did three important things at once. First, it replaced a vague continuation debate with a specific tender architecture. Second, it took the largest hostile holder and forced it into the in specie lane, which mechanically frees cash capacity for everyone else. Third, it paired that tender with a continuity package: same manager, same mandate, larger operating platform. Source

The balance-sheet plumbing matters. Herald said the need for forced realizations is reduced because the trust already holds about 23.5% of its portfolio in cash and cash equivalents. Its 13 May statistics report showed 23.6% in cash and government bonds at 30 April, no gearing, and 251 equity holdings. Source Source

This is why the case is cleaner than a typical wide-discount trust. The board is not promising a clean exit while sitting on an illiquid book with no liquidity buffer. It is promising a partial exit with cash already in hand, a forced seller already routed away from the cash lane, and a timetable that starts this month.

The Market Price

The live tape is still behind the paperwork. Fidelity's 18 May quote showed 3,000p bid and 3,015p offer, versus estimated NAV of 3,263.28p. That is the market saying the stock deserves to trade roughly 8% cheap even after the tender blueprint was published. Source

The official NAV is higher. Herald's RNS put ex-income NAV at 3,321.44p as of 15 May. If you take the cash-option formula exactly as published, the cash leg clears at NAV less 2% less allocated costs. On the Fidelity estimated NAV, that is about 3,198p before costs. On the 15 May official NAV, it is about 3,255p before costs. Either way, the listed shares at 3,015p still sit below the published exit formula. Source Source

Average daily value traded, per Fidelity, is about 3.13 million GBP. That is enough liquidity for a real common-stock expression. Source

The Positioning

The positioning claim here is unusually direct because it sits in the company announcement itself. Saba is not merely a noisy holder. It is the large shareholder around which the deal is engineered. Herald says Saba owns about 30% of the stock, will tender that full line in specie, will vote for the plan, will not seek board change, and will not short the shares for three years once the package is implemented. Source

That changes the cash-exit math for everybody else. Herald says Saba's election guarantees at least about 51% cash exit capacity for other holders, with potentially more depending on take-up. The market is still pricing the stock like cash capacity is the scarce resource. The filing says the opposite. Source

There is a second positioning angle that matters just as much. Long-term holders who like Potts' process and have embedded gains do not need to sell. The board explicitly framed the continuation option as a way to avoid forcing a tax event on that cohort. If that reading is right, the market's worst-case assumption, that everyone except Saba rushes for cash, is too pessimistic. Source

The Catalyst

The catalyst path is visible and short-dated. Herald expects the circular and notice of general meeting around the end of May, the shareholder vote toward the end of June, and completion in July. The management transition to Aberdeen is expected at the start of August. The standstill survives through the 2029 AGM if the proposals are implemented by 30 September 2026. Source

This matters because the market does not need to wait for the whole tender to finish before re-pricing the discount. The next catalyst is the circular. Once the detailed mechanics, costs, and election procedures are public, the discount should trade against a more precise formula rather than a generic activist discount.

The Gap

The market appears to be pricing Herald as if three risks are still dominant: forced selling, unresolved activism, and an unattractive orphan stub after the exit. The filings narrow all three.

Forced selling is partly offset by the trust's cash pile and by the in specie lane. The activist is no longer a wild card if the deal closes; it becomes a departing holder under standstill terms. The continuation vehicle is not a new strategy or new manager search. It is Katie Potts, the existing mandate, and Aberdeen's distribution and balance-sheet support.

That leaves a simpler disagreement. Is an 8% whole-line discount still fair when other holders have a published path to sell a meaningful chunk of stock close to NAV, and when the largest dissident holder has already agreed to leave through the non-cash route? My answer is no. The discount should narrow before the vote unless the circular exposes much higher costs or a real timetable problem.

The Payoff Map

This is not a classic deep-value liquidation bet. It is a discount-compression trade with a corporate-action floor. The cleanest expression is long common stock into the circular and vote. I do not see a practical options expression to improve it.

The base case is not that Herald trades to full NAV. The base case is that the market starts valuing the listed line closer to the cash-option formula and stops charging an activist-orphan discount once the circular lands. The top case is that take-up is lighter than feared, the remaining vehicle looks viable, and the shares rerate toward a very tight discount. The bottom case is that the documentation slips, the small-cap tech portfolio drops, or the market decides the post-tender vehicle deserves a permanently wider discount.

Price Target and Probability Map

Scenario	Probability	Target / Level	Return / Payoff	Time Horizon	Conditions Required	Evidence Quality
Top Case	30%	3360p	+11.4%	6 to 10 weeks	Circular lands on time, vote path stays intact, discount tightens to roughly 0% to 3% on stable or firmer NAV	Medium
Base Case	50%	3200p	+6.1%	6 to 10 weeks	Tender terms remain close to the announced framework, market prices the cash-option math, but keeps some residual stub discount	High
Bottom Case	20%	2760p	-8.5%	6 to 10 weeks	Definitive documents wobble, portfolio beta turns against the trust, or discount widens back into activist-deadlock territory	Medium
Invalidation / Stop Condition	n/a	2825p	-6.3%	Immediate on trigger	Circular slips materially past mid-June, Aberdeen or HIML documentation breaks, or the discount widens beyond about 13% without a matching NAV hit	High

Probability-weighted expected value: About +4.8% before fees, stamp duties, and FX.

Current market price / level: 3,015p offer, 3,000p bid, estimated NAV 3,263.28p.

Timestamp: 18 May 2026 23:49 Singapore time for the Fidelity quote; official ex-income NAV 3,321.44p as of 15 May 2026, published 18 May 2026.

Primary instrument: Herald Investment Trust common shares.

Alternative expressions considered: Waiting to elect into the cash option after the circular; the in specie route for very large holders; no practical listed-options expression verified.

Confidence: Medium.

What Could Go Wrong

The strongest counterargument is straightforward: the market is not mispricing the exit, it is pricing the post-exit stub. After a big tender, Herald will be smaller, its cost ratio could look worse, and the remaining vehicle could still trade on a discount because the underlying portfolio is volatile and global small-cap tech is not a sleepy asset base.

There is also real execution risk. The circular is not out yet. The final cost allocation is not yet printed. The cash option is capped and scaled, even if the guaranteed capacity is better than the market seems to assume. If the portfolio sells off before the calculation date, the tender formula falls with it. If the documentation between Herald, HIML, and Aberdeen stumbles, the whole setup de-rates immediately.

What Would Prove This Wrong

This fails if the board cannot publish the circular on roughly the timetable it announced, if the definitive Aberdeen package weakens the continuity story, or if the final tender economics show materially larger friction than the market currently expects. It also fails if the shares tighten to a very small discount before those confirmations arrive. At that point the edge is gone, even if the deal still closes.

Bottom Line

Herald is not cheap because the market loves the portfolio. It is cheap because the market still treats the stock as an unresolved governance fight. The filings say the fight is moving into documentation, not warfare. At roughly 3,015p against a published exit formula tied to NAV, the cleaner trade is to own the common shares and let the discount do the work.